Dishevelled-1 DIX and PDZ domain lysine residues regulate oncogenic Wnt signaling
Dishevelled-1 DIX and PDZ domain lysine residues regulate oncogenic Wnt signaling |
|
https://doi.org/10.18632/oncotarget.28089
Monica Sharma,
Isabel Castro-Piedras,
Fahmida Rasha,
Sabarish Ramachandran,
Souad R. Sennoune,
Kathryn Furr,
Sharilyn Almodovar,
Vadivel Ganapathy,
Matthew B. Grisham,
Rakhshanda Layeequr Rahman,
and Kevin Pruitt
|
| 2234-2251 |
P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses
P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses |
|
https://doi.org/10.18632/oncotarget.28083
Issam Makhoul,
Saddam Mohammed Ibrahim,
Muhammad Abu-Rmaileh,
Fariba Jousheghany,
Eric R. Siegel,
Lora J. Rogers,
John J. Lee,
Sergio Pina-Oviedo,
Ginell R. Post,
J. Thaddeus Beck,
Thomas Kieber-Emmons,
and Behjatolah Monzavi-Karbassi
|
| 2252-2265 |
THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.28099
Phyllis A. Gimotty,
Jacob E. Till,
Shirsa Udgata,
Naomi Takenaka,
Stephanie S. Yee,
Michael J. LaRiviere,
Mark H. O’Hara,
Kim A. Reiss,
Peter O'Dwyer,
Bryson W. Katona,
Daniel Herman,
Erica L. Carpenter,
and Kenneth S. Zaret
|
| 2266-2272 |
Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization
Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization |
|
https://doi.org/10.18632/oncotarget.28092
Christina Schmitt,
Anna-Alice Schulz,
Ria Winkelmann,
Kevin Smith,
Peter J. Wild,
and Melanie Demes
|
| 2273-2282 |
Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy
Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy |
|
https://doi.org/10.18632/oncotarget.28091
Ana Chor,
Maria Adriana Skeff,
Christina Takiya,
Raquel Gonçalves,
Marcos Dias,
Marcos Farina,
Leonardo R. Andrade,
and Valeria de Mello Coelho
|
| 2283-2299 |
Future directions for immunotherapy in meningioma treatment
Future directions for immunotherapy in meningioma treatment |
|
https://doi.org/10.18632/oncotarget.27994
John W. Rutland,
Jonathan T. Dullea,
and Raj K. Shrivastava
|
| 2300-2301 |
Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer
Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer |
|
https://doi.org/10.18632/oncotarget.28007
Sasagu Kurozumi,
Ayaka Katayama,
Ken Shirabe,
Jun Horiguchi,
and Emad A. Rakha
|
| 2302-2304 |
Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival |
|
https://doi.org/10.18632/oncotarget.28093
Sara Maimouni,
Mi-Hye Lee,
You-Me Sung,
Michael Hall,
Arpita Roy,
Chokri Ouaari,
Yoo-Seok Hwang,
Justin Spivak,
Eric Glasgow,
Matthew Swift,
Jay Patel,
Amrita Cheema,
Deepak Kumar,
and Stephen Byers
|
| 2305-2306 |
